Revise Information

Revise developed the Relay platform to give sponsors a different way to communicate with sites–at any clinical trial size. Sponsors use Relay to share information, manage performance, and coordinate patients across hundreds of sites. Too many sponsor teams struggle with site communication, especially on large trials. For example, they: - Get buried in manual processes and one-off conversations - Have trouble keeping important info top of mind with sites - Feel removed from sites, no matter what metrics they have With Relay, sponsor teams can now: - Use vendors without losing direct impact at sites - Replace scattered interaction with one organized system - Preserve what matters when people move on Top-20 pharma sponsors have used the Relay platform in global trials for over 7 years. Our team first launched Relay as a patient recruitment portal, then realized something. Many recruitment and other trial challenges were really about communication. So we went to work making Relay into the communication hub we thought should exist. Who We Are Sponsors have relied on our clinical trial and technology expertise for 15 years, previously as Rebar Interactive and now as Revise. We’ve helped teams navigate their most complex clinical operations challenges, on global and high-profile programs for GLP-1s, COVID, and much more. Revise is funded by customers and backed by an agile, high-performing team of trial veterans. Each member of our core team has worked in clinical trials at least 18 years, whether at sites, CROs, or Revise. We are guided only by our expertise and the needs of those we serve, not investors. Revise is also the only trial tech company led by a former research coordinator. Our founder has a deep appreciation for site frustration and a strong desire to alleviate it. This desire is why Revise was founded and is independently owned.